2022
Prognostic value of age-sex adjusted NT-proBNP ratio in obstructive hypertrophic cardiomyopathy
Hutt E, Mentias A, Alashi A, Wadhwa R, Fava A, Lever HM, Thamilarasan M, Popovic ZB, Smedira NG, Desai MY. Prognostic value of age-sex adjusted NT-proBNP ratio in obstructive hypertrophic cardiomyopathy. Progress In Cardiovascular Diseases 2022, 74: 11-18. PMID: 35952727, DOI: 10.1016/j.pcad.2022.08.002.Peer-Reviewed Original ResearchConceptsSeptal reduction therapyBNP ratioNT-proBNP ratioPrimary outcomeAsymptomatic patientsPrognostic valueObstructive hypertrophic cardiomyopathy patientsIncremental prognostic valueNormal NT-proBNPNT-pro BNPObstructive hypertrophic cardiomyopathyLong-term outcomesHypertrophic cardiomyopathy patientsCardiac transplantationNT-proBNPPrimary endpointCardiomyopathy patientsHypertrophic cardiomyopathyReduction therapyHigh riskPatientsDefibrillator dischargeSpline analysisOutcomesBNP
2021
Predictive value of NT-proBNP in non-obstructive hypertrophic cardiomyopathy
Hutt E, Mentias A, Alashi A, Fava A, Popovic Z, Thamilarasan M, Lever H, Desai M. Predictive value of NT-proBNP in non-obstructive hypertrophic cardiomyopathy. European Heart Journal 2021, 42: ehab724.0765. DOI: 10.1093/eurheartj/ehab724.0765.Peer-Reviewed Original ResearchNT-proBNP ratioLV ejection fractionSerum NT-proBNPNT-proBNPAsymptomatic patientsPrimary endpointSeptal myectomySudden cardiac death risk factorsNon-obstructive hypertrophic cardiomyopathyKaplan-Meier survival analysisDeath risk factorsEarly disease stagesHypertrophic cardiomyopathy patientsImplantable defibrillator dischargesEjection fractionHeart transplantPrimary outcomeRisk stratificationPrognostic valueAdverse outcomesDisease stageCardiomyopathy patientsRisk factorsEcho variablesHypertrophic cardiomyopathy
2020
Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function
Alashi A, Isaza N, Faulx J, Popovic ZB, Menon V, Ellis SG, Faulx M, Kapadia SR, Griffin BP, Desai MY. Characteristics and Outcomes of Patients With Takotsubo Syndrome: Incremental Prognostic Value of Baseline Left Ventricular Systolic Function. Journal Of The American Heart Association 2020, 9: e016537. PMID: 32755253, PMCID: PMC7660826, DOI: 10.1161/jaha.120.016537.Peer-Reviewed Original ResearchConceptsBaseline LV ejection fractionLV ejection fractionIncremental prognostic valueLV-GLSTakotsubo syndromePrognostic valueLower baseline LV ejection fractionObstructive coronary artery diseaseVentricular global longitudinal strainMultivariate Cox survival analysisMean LV ejection fractionWorse LV-GLSOutcomes of patientsPrimary end pointVentricular systolic functionCoronary artery diseaseGlobal longitudinal strainLong-term outcomesCox survival analysisPhysical triggersPrognostic cutoffCause mortalityApical ballooningConclusions PatientsSystolic function
2019
P6152Incremental prognostic utility of functionally non-significant coronary stenosis in patients undergoing coronary computed tomogram angiography
Alashi A, Huttcenteno E, Schoenhagen P, Popovic Z, Cremer P, Kalahasti V, Jellis C, Renapurkar R, Rodriguez L, Flamm S, Desai M. P6152Incremental prognostic utility of functionally non-significant coronary stenosis in patients undergoing coronary computed tomogram angiography. European Heart Journal 2019, 40: ehz746.0758. DOI: 10.1093/eurheartj/ehz746.0758.Peer-Reviewed Original ResearchHigh-risk plaque featuresCoronary artery diseasePlaque featuresModerate stenosisPrognostic utilityPrognostic valueNon-significant coronary artery diseaseHigh pre-test likelihoodMultivariable Cox survival analysisNon-significant coronary stenosisPrior coronary artery diseaseSevere coronary artery diseaseLong-term event ratesFractional flow reserve assessmentComposite of deathIncremental prognostic valueIntermediate-risk patientsMinimal luminal irregularitiesNonobstructive coronary plaqueLong-term freedomEpicardial coronary arteriesHistory of smokingPre-test likelihoodTraditional risk factorsIncremental prognostic utilityIncremental Prognostic Value of Exercise Stress Testing in Primary Prevention
Alashi A, Riaz H, Lang R, Seballos R, Feinleib S, Sukol R, Cho L, Cremer P, Jaber W, Griffin BP, Desai MY. Incremental Prognostic Value of Exercise Stress Testing in Primary Prevention. The American Journal Of Cardiology 2019, 124: 216-223. PMID: 31104779, DOI: 10.1016/j.amjcard.2019.04.021.Peer-Reviewed Original ResearchConceptsHeart rate recoveryIncremental prognostic valueC-reactive proteinPrimary preventionPrognostic valueLong-term eventsCV diseaseDerivation groupFamily historyValidation groupStandard risk factor assessmentProspective observational cohort studyContinuous net reclassification improvementConsecutive asymptomatic adultsPremature CV diseaseSuperior risk stratificationTreadmill stress testingFuture cardiovascular eventsObservational cohort studyExercise stress testingMultivariable survival analysisRisk factor assessmentNet reclassification improvementBeats/minStress testing
2018
3136Incremental and synergistic prognostic value of exercise stress testing and standard risk factor assessment in asymptomatic executives: a primary prevention study
Alashi A, Young L, Lang R, Seballos R, Feinleib S, Sukol R, Cho L, Cremer P, Jaber W, Griffin B, Desai M. 3136Incremental and synergistic prognostic value of exercise stress testing and standard risk factor assessment in asymptomatic executives: a primary prevention study. European Heart Journal 2018, 39: ehy563.3136. DOI: 10.1093/eurheartj/ehy563.3136.Peer-Reviewed Original Research